CME Group Inc. (NASDAQ:CME) Shares Sold by Joel Isaacson & Co. LLC

Joel Isaacson & Co. LLC reduced its holdings in shares of CME Group Inc. (NASDAQ:CME) by 16.8% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 1,210 shares of the financial services provider’s stock after selling 245 shares during the period. Joel Isaacson & Co. LLC’s holdings in CME Group were worth $267,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Trueblood Wealth Management LLC acquired a new position in CME Group during the 3rd quarter worth $222,000. Ballentine Partners LLC increased its holdings in CME Group by 6.9% in the third quarter. Ballentine Partners LLC now owns 5,416 shares of the financial services provider’s stock valued at $1,195,000 after buying an additional 351 shares during the last quarter. Mount Yale Investment Advisors LLC raised its stake in CME Group by 4.1% during the third quarter. Mount Yale Investment Advisors LLC now owns 10,088 shares of the financial services provider’s stock valued at $2,226,000 after buying an additional 398 shares in the last quarter. Eagle Ridge Investment Management lifted its holdings in CME Group by 78.6% during the 3rd quarter. Eagle Ridge Investment Management now owns 123,257 shares of the financial services provider’s stock worth $27,197,000 after buying an additional 54,238 shares during the last quarter. Finally, Assenagon Asset Management S.A. grew its position in shares of CME Group by 15.4% in the 3rd quarter. Assenagon Asset Management S.A. now owns 744,844 shares of the financial services provider’s stock worth $164,350,000 after acquiring an additional 99,514 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Stock Performance

Shares of CME opened at $226.14 on Friday. The firm has a market capitalization of $81.43 billion, a PE ratio of 25.73, a P/E/G ratio of 7.76 and a beta of 0.55. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. The firm has a 50-day moving average price of $218.94 and a 200 day moving average price of $208.89. CME Group Inc. has a 52-week low of $190.70 and a 52-week high of $230.36.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.65 by $0.03. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The business had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same period last year, the firm posted $2.25 earnings per share. The business’s revenue was up 18.4% on a year-over-year basis. On average, sell-side analysts anticipate that CME Group Inc. will post 10.04 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were paid a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.03%. The ex-dividend date was Monday, September 9th. CME Group’s dividend payout ratio is presently 52.33%.

Wall Street Analyst Weigh In

CME has been the topic of several research analyst reports. Citigroup raised their price objective on CME Group from $250.00 to $255.00 and gave the stock a “buy” rating in a research note on Thursday. Oppenheimer lifted their price target on shares of CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a report on Thursday. Morgan Stanley boosted their price objective on shares of CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research report on Thursday, October 17th. JPMorgan Chase & Co. raised their target price on shares of CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a report on Thursday, July 25th. Finally, Redburn Atlantic lowered CME Group from a “buy” rating to a “neutral” rating and set a $244.00 target price for the company. in a report on Tuesday, October 8th. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, CME Group presently has a consensus rating of “Hold” and an average price target of $222.07.

Insider Activity

In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the sale, the chief financial officer now directly owns 13,261 shares in the company, valued at approximately $2,877,504.39. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now directly owns 55,607 shares in the company, valued at $11,932,706.13. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the sale, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.30% of the company’s stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.